Skip to main content
Premium Trial:

Request an Annual Quote

AB Sciex API 3200MD and 3200MD QTRAP Mass Specs Receive EU CE-IVDD Mark


AB Sciex this week said that its API 3200MD and 3200MD QTRAP mass spectrometers have received the EU CE-IVDD mark, allowing them to be sold in the EU for general in vitro diagnostic use including in hospitals and clinical diagnostic laboratories.

The announcement follows on the release in February of the 3200MD and 3200MD QTRAP in the US as US Food and Drug Administration Class I exempt medical devices (PM 2/15/2013).

"We are focused on meeting the medical, technological and compliance needs of clinical diagnostic laboratories and hospitals," AB Sciex president Rainer Blair, said in a statement, adding that he expected the EU release of the devices to "simplify and accelerate [clinical] adoption of this powerful technology."

The company said that it plans to continue to release regulatory compliant mass spec systems around the world, pursuing a strategy of expanding the use of mass spec technology in clinical diagnostics.

The 3200MD and 3200MD QTRAP are slated to begin shipping in Europe by mid-June.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.